Literature DB >> 1984409

Correlation of metabolic stability and altered quaternary structure of oncoprotein p53 with cell transformation.

S Kraiss1, S Spiess, E Reihsaus, M Montenarh.   

Abstract

The phosphoprotein p53 seems to be implicated in various processes connected with cell transformation and in particular with the regulation of cell cycle and probably DNA replication. In the present paper we have analyzed two sets of closely related cell lines expressing the same p53 which exhibited either a nontransformed or a transformed phenotype. These cell lines were used to study biochemical properties of the p53 protein which might be correlated with cell transformation. We found a positive correlation among an elevated stability of p53, the formation of high-molecular-weight forms of p53, and the transformed phenotype of the corresponding cell lines. Furthermore, these data indicate that self-aggregation prevents p53 from rapid degradation. By a comparative analysis of the stability and oligomerization properties of mutant p53 and wild-type p53, we could demonstrate that elevated stability and self-aggregation of p53 are correlated with the transformed phenotype of the cells and independent of a particular mutation in the p53 gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984409     DOI: 10.1016/0014-4827(91)90170-y

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome.

Authors:  A Reles; A Schmider; M F Press; I Schönborn; W Friedmann; S Huber-Schumacher; T Strohmeyer; W Lichtenegger
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  p53 protein aggregation promotes platinum resistance in ovarian cancer.

Authors:  Y Yang-Hartwich; M G Soteras; Z P Lin; J Holmberg; N Sumi; V Craveiro; M Liang; E Romanoff; J Bingham; F Garofalo; A Alvero; G Mor
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

4.  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Authors:  Sofia Levva; Vassiliki Kotoula; Ioannis Kostopoulos; Kyriaki Manousou; Christos Papadimitriou; Kyriaki Papadopoulou; Sotiris Lakis; Kyriakos Koukoulias; Vasilios Karavasilis; George Pentheroudakis; Eufemia Balassi; Flora Zagouri; Ioannis G Kaklamanos; Dimitrios Pectasides; Evangelia Razis; Gerasimos Aravantinos; Pavlos Papakostas; Dimitrios Bafaloukos; Grigorios Rallis; Helen Gogas; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

5.  Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.

Authors:  Rainer Wilcken; GuoZhen Wang; Frank M Boeckler; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

6.  The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule.

Authors:  Domenic Vital; Gerhard F Huber; David Holzmann; Holger Moch; Kristian Ikenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-01       Impact factor: 2.503

7.  Factors affecting platinum sensitivity in cervical cancer.

Authors:  Rina Kato; Kiyoshi Hasegawa; Yutaka Torii; Yasuhiro Udagawa; Ichio Fukasawa
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

8.  Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution.

Authors:  H Sakamoto; M S Lewis; H Kodama; E Appella; K Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.

Authors:  E Latres; M Drobnjak; D Pollack; M R Oliva; M Ramos; M Karpeh; J M Woodruff; C Cordon-Cardo
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.

Authors:  C Poremba; D W Yandell; Q Huang; J B Little; W Mellin; K W Schmid; W Böcker; B Dockhorn-Dworniczak
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.